跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POVIDONE IODINE TOPICAL SOLUTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
POVIDONE IODINE TOPICAL SOLUTION
Authorized
STANDARD
POVIDONE IODINE TOPICAL SOLUTION
James Alexander Corp
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
38c4d5c81b87df60
Company
James Alexander Corp
Type
Standard
Approval Details
Approval Id
38c4d5c81b87df60
Drug Approval Canada Name
POVIDONE IODINE TOPICAL SOLUTION
Product Name
POVIDONE IODINE TOPICAL SOLUTION
Status
Cancelled Post Market
Status Date
2008-07-31
Original Market Date
1997-03-31
Din
02230501
Drug Class
Human
Dosage Form
Liquid
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:04.92
Atc Original
D08AG02 POVIDONE-IODINE
Atc Name
d 08 ag 02
Aig Number
0107785020
Company Name
James Alexander Corp
Company Address
845 Route 94, Blairstown, New Jersey, United States, 07825
Company Detail Path
/organization/james-alexander-corp
Company Information
Pharmaceutical Company Name
James Alexander Corp
Country Name
United States
Province Name
New Jersey
City Name
blairstown,new jersey,country_us
Address
845 State Route 94
Active Ingredients
POVIDONE-IODINE
1 % / 0.6 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
38c4d5c81b87df60
Type
Standard
Back to Health Canada Approvals